IgA subclasses in various secretions and in serum

Immune biomarker evaluation of sequential tyrosine kinase inhibitor and nivolumab monotherapies in renal cell carcinoma: the phase I TRIBE trial.

Immuno-oncology technology·2024

Plasma Tie2 trajectories identify vascular response criteria for VEGF inhibitors across advanced biliary tract, colorectal and ovarian cancers.

ESMO open·2022

iRFP (near-infrared fluorescent protein) imaging of subcutaneous and deep tissue tumours in mice highlights differences between imaging platforms.

Cancer cell international·2021

Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome.

ESMO open·2021

How liquid biopsies can change clinical practice in oncology.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer.

European journal of cancer (Oxford, England : 1990)·2019

Immunometabolic Modulation by Low-Dose Sodium Butyrate: PI3K/Akt/mTOR Signalling Orchestrates Macrophage Polarization to Protect Against Clostridioides difficile Colitis.

Immunology·2026

A PD1-CD137L Fusion Protein More Potently Enhances Anti-Tumour Immune Responses Than Targeting PD-L1 and CD137 Separately.

Immunology·2026

Myo1g Mediates NKR-P1C Expression in Primary Mouse NK Cells and Participates in Cytotoxicity.

Immunology·2026

MyD88-Family Adaptors: Compartmentalised Signalling and Non-Immune Functions.

Immunology·2026

Metabolic Profiling of Circulating and Tumour-Infiltrating T Cells Uncovers Bioenergetic Checkpoints Linked With Immune and Clinical Skewing in Melanoma Patients.

Immunology·2026

Interleukin-18 Constrains the Intestinal Tuft Cell-Driven Responses During Helminth Infection.

Immunology·2026

LIMK1 and PKM as Integratively Identified Transcriptomic Signatures in Inflammatory Bowel Disease.

Omics : a journal of integrative biology·2026

[Diagnosis and Treatment Experience in a Case of Visceral Leishmaniasis Co-infected with HIV].

Mikrobiyoloji bulteni·2026

Related Experiment Videos

IgA subclasses in various secretions and in serum

Related Concept Videos

Immune biomarker evaluation of sequential tyrosine kinase inhibitor and nivolumab monotherapies in renal cell carcinoma: the phase I TRIBE trial.

Plasma Tie2 trajectories identify vascular response criteria for VEGF inhibitors across advanced biliary tract, colorectal and ovarian cancers.

iRFP (near-infrared fluorescent protein) imaging of subcutaneous and deep tissue tumours in mice highlights differences between imaging platforms.

Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome.

How liquid biopsies can change clinical practice in oncology.

EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer.

Immunometabolic Modulation by Low-Dose Sodium Butyrate: PI3K/Akt/mTOR Signalling Orchestrates Macrophage Polarization to Protect Against Clostridioides difficile Colitis.

A PD1-CD137L Fusion Protein More Potently Enhances Anti-Tumour Immune Responses Than Targeting PD-L1 and CD137 Separately.

Myo1g Mediates NKR-P1C Expression in Primary Mouse NK Cells and Participates in Cytotoxicity.

MyD88-Family Adaptors: Compartmentalised Signalling and Non-Immune Functions.

Metabolic Profiling of Circulating and Tumour-Infiltrating T Cells Uncovers Bioenergetic Checkpoints Linked With Immune and Clinical Skewing in Melanoma Patients.

Interleukin-18 Constrains the Intestinal Tuft Cell-Driven Responses During Helminth Infection.

LIMK1 and PKM as Integratively Identified Transcriptomic Signatures in Inflammatory Bowel Disease.

[Diagnosis and Treatment Experience in a Case of Visceral Leishmaniasis Co-infected with HIV].

Related Experiment Videos

IgA subclasses in various secretions and in serum

Related Concept Videos

Related Articles